Dechra Pharmaceuticals

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Our key focus therapeutic areas are: • Endocrinology • Dermatology • Anaesthesia and analgesia • Ophthalmology • Cardiovascular disease • Equine locomotion • Food producing animal antimicrobials • And pet diets
Type
Public
HQ
Lostock Gralam, GB
Founded
1997
Size (employees)
1,308 (est)+52%
Dechra Pharmaceuticals was founded in 1997 and is headquartered in Lostock Gralam, GB

Dechra Pharmaceuticals Office Locations

Dechra Pharmaceuticals has offices in Lostock Gralam, Hadnall, Skipton, Melbourne and in 6 other locations
Lostock Gralam, GB
Torino, IT
Barcelona, ES
Uldum, DK
Upplands Väsby, SE
Pointe-Claire, CA
Leawood, US
Melbourne, US
Skipton, GB
Hadnall, GB

Dechra Pharmaceuticals Metrics

Dechra Pharmaceuticals Summary

Market capitalization

£1.6 b

Closing share price

£16.8
Dechra Pharmaceuticals's current market capitalization is £1.6 b.

Dechra Pharmaceuticals Financials

Dechra Pharmaceuticals's revenue is £189.2 m in FY, 2013 which is a 2.3% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

£189.2 m£193.6 m£203.5 m£247.6 m

Revenue growth, %

2.3%5.1%21.7%

Cost of sales

£88.5 m£85.9 m£87.3 m£115.1 m

Gross profit

£100.7 m£107.7 m£116.1 m£132.4 m

Gross profit Margin, %

53.2%55.6%57.1%53.5%

Operating expense total

£82.4 m£82.7 m£90.2 m£112.9 m

Dechra Pharmaceuticals Market Value History

Dechra Pharmaceuticals Job Categories

Dechra Pharmaceuticals Online Presence

Dechra Pharmaceuticals News

Dechra Pharmaceuticals Company Life

You may also be interested in